Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Gut health may influence Alopecia Areata, suggesting new treatments.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Mice can grow new hair follicles after skin wounds through a process not involving existing hair stem cells, but requiring more research to understand fully.

Alefacept does not effectively treat severe alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Ku80 is a key receptor for Thymosin β4, affecting cell migration and wound healing.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Ebastine may help regrow hair in alopecia areata patients.

People with alopecia areata are more likely to have other immune-related conditions.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

SLHA can be hard to diagnose and needs teamwork between specialists.